PandemieGrippaleV1, PubMed, Checkpoint, bibRecord, 001245

Investment in antiviral drugs: a real options approach.

Identifieur interne : 001245 ( PubMed/Checkpoint ); précédent : 001244; suivant : 001246

Investment in antiviral drugs: a real options approach.

Auteurs : Arthur E. Attema [Pays-Bas] ; Anna K. Lugnér ; Talitha L. Feenstra

Source :

Health economics [ 1099-1050 ] ; 2010.

RBID : pubmed:19816857

Descripteurs français

KwdFr :
- Antiviraux (ressources et distribution), Antiviraux (usage thérapeutique), Antiviraux (économie), Coûts et analyse des coûts, Facteurs temps, Grippe humaine (traitement médicamenteux), Grippe humaine (économie), Humains, Incertitude, Modèles économiques, Pandémies (économie), Services de santé (), Services de santé (économie), Évaluation des risques.
MESH :
- ressources et distribution : Antiviraux.
- traitement médicamenteux : Grippe humaine.
- usage thérapeutique : Antiviraux.
- économie : Antiviraux, Grippe humaine, Pandémies, Services de santé.
- Coûts et analyse des coûts, Facteurs temps, Humains, Incertitude, Modèles économiques, Services de santé, Évaluation des risques.

English descriptors

KwdEn :
- Antiviral Agents (economics), Antiviral Agents (supply & distribution), Antiviral Agents (therapeutic use), Costs and Cost Analysis, Health Services (economics), Health Services (statistics & numerical data), Humans, Influenza, Human (drug therapy), Influenza, Human (economics), Models, Economic, Pandemics (economics), Risk Assessment, Time Factors, Uncertainty.
MESH :
- chemical , economics : Antiviral Agents.
- chemical , supply & distribution : Antiviral Agents.
- chemical , therapeutic use : Antiviral Agents.
- drug therapy : Influenza, Human.
- economics : Health Services, Influenza, Human, Pandemics.
- statistics & numerical data : Health Services.
- Costs and Cost Analysis, Humans, Models, Economic, Risk Assessment, Time Factors, Uncertainty.

Abstract

Real options analysis is a promising approach to model investment under uncertainty. We employ this approach to value stockpiling of antiviral drugs as a precautionary measure against a possible influenza pandemic. Modifications of the real options approach to include risk attitude and deviations from expected utility are presented. We show that risk aversion counteracts the tendency to delay investment for this case of precautionary investment, which is in contrast to earlier applications of risk aversion to real options analysis. Moreover, we provide a numerical example using real world data and discuss the implications of real options analysis for health policy. Suggestions for further extensions of the model and a comparison with the expected value of information analysis are put forward.

DOI: 10.1002/hec.1549
PubMed: 19816857

Affiliations:

Pays-Bas

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001602
to stream PubMed, to step Curation: 001602

Links to Exploration step

pubmed:19816857

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Investment in antiviral drugs: a real options approach.</title>
<author><name sortKey="Attema, Arthur E" sort="Attema, Arthur E" uniqKey="Attema A" first="Arthur E" last="Attema">Arthur E. Attema</name>
<affiliation wicri:level="1"><nlm:affiliation>Center for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Center for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lugner, Anna K" sort="Lugner, Anna K" uniqKey="Lugner A" first="Anna K" last="Lugnér">Anna K. Lugnér</name>
</author>
<author><name sortKey="Feenstra, Talitha L" sort="Feenstra, Talitha L" uniqKey="Feenstra T" first="Talitha L" last="Feenstra">Talitha L. Feenstra</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:19816857</idno>
<idno type="pmid">19816857</idno>
<idno type="doi">10.1002/hec.1549</idno>
<idno type="wicri:Area/PubMed/Corpus">001602</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001602</idno>
<idno type="wicri:Area/PubMed/Curation">001602</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001602</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001245</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001245</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Investment in antiviral drugs: a real options approach.</title>
<author><name sortKey="Attema, Arthur E" sort="Attema, Arthur E" uniqKey="Attema A" first="Arthur E" last="Attema">Arthur E. Attema</name>
<affiliation wicri:level="1"><nlm:affiliation>Center for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Center for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven</wicri:regionArea>
<wicri:noRegion>Bilthoven</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lugner, Anna K" sort="Lugner, Anna K" uniqKey="Lugner A" first="Anna K" last="Lugnér">Anna K. Lugnér</name>
</author>
<author><name sortKey="Feenstra, Talitha L" sort="Feenstra, Talitha L" uniqKey="Feenstra T" first="Talitha L" last="Feenstra">Talitha L. Feenstra</name>
</author>
</analytic>
<series><title level="j">Health economics</title>
<idno type="eISSN">1099-1050</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (economics)</term>
<term>Antiviral Agents (supply & distribution)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Costs and Cost Analysis</term>
<term>Health Services (economics)</term>
<term>Health Services (statistics & numerical data)</term>
<term>Humans</term>
<term>Influenza, Human (drug therapy)</term>
<term>Influenza, Human (economics)</term>
<term>Models, Economic</term>
<term>Pandemics (economics)</term>
<term>Risk Assessment</term>
<term>Time Factors</term>
<term>Uncertainty</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux (ressources et distribution)</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Antiviraux (économie)</term>
<term>Coûts et analyse des coûts</term>
<term>Facteurs temps</term>
<term>Grippe humaine (traitement médicamenteux)</term>
<term>Grippe humaine (économie)</term>
<term>Humains</term>
<term>Incertitude</term>
<term>Modèles économiques</term>
<term>Pandémies (économie)</term>
<term>Services de santé ()</term>
<term>Services de santé (économie)</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="economics" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="supply & distribution" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Health Services</term>
<term>Influenza, Human</term>
<term>Pandemics</term>
</keywords>
<keywords scheme="MESH" qualifier="ressources et distribution" xml:lang="fr"><term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Health Services</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Antiviraux</term>
<term>Grippe humaine</term>
<term>Pandémies</term>
<term>Services de santé</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Costs and Cost Analysis</term>
<term>Humans</term>
<term>Models, Economic</term>
<term>Risk Assessment</term>
<term>Time Factors</term>
<term>Uncertainty</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Coûts et analyse des coûts</term>
<term>Facteurs temps</term>
<term>Humains</term>
<term>Incertitude</term>
<term>Modèles économiques</term>
<term>Services de santé</term>
<term>Évaluation des risques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Real options analysis is a promising approach to model investment under uncertainty. We employ this approach to value stockpiling of antiviral drugs as a precautionary measure against a possible influenza pandemic. Modifications of the real options approach to include risk attitude and deviations from expected utility are presented. We show that risk aversion counteracts the tendency to delay investment for this case of precautionary investment, which is in contrast to earlier applications of risk aversion to real options analysis. Moreover, we provide a numerical example using real world data and discuss the implications of real options analysis for health policy. Suggestions for further extensions of the model and a comparison with the expected value of information analysis are put forward.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19816857</PMID>
<DateCompleted><Year>2011</Year>
<Month>01</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>12</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1099-1050</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>19</Volume>
<Issue>10</Issue>
<PubDate><Year>2010</Year>
<Month>Oct</Month>
</PubDate>
</JournalIssue>
<Title>Health economics</Title>
<ISOAbbreviation>Health Econ</ISOAbbreviation>
</Journal>
<ArticleTitle>Investment in antiviral drugs: a real options approach.</ArticleTitle>
<Pagination><MedlinePgn>1240-54</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/hec.1549</ELocationID>
<Abstract><AbstractText>Real options analysis is a promising approach to model investment under uncertainty. We employ this approach to value stockpiling of antiviral drugs as a precautionary measure against a possible influenza pandemic. Modifications of the real options approach to include risk attitude and deviations from expected utility are presented. We show that risk aversion counteracts the tendency to delay investment for this case of precautionary investment, which is in contrast to earlier applications of risk aversion to real options analysis. Moreover, we provide a numerical example using real world data and discuss the implications of real options analysis for health policy. Suggestions for further extensions of the model and a comparison with the expected value of information analysis are put forward.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Attema</LastName>
<ForeName>Arthur E</ForeName>
<Initials>AE</Initials>
<AffiliationInfo><Affiliation>Center for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lugnér</LastName>
<ForeName>Anna K</ForeName>
<Initials>AK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Feenstra</LastName>
<ForeName>Talitha L</ForeName>
<Initials>TL</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Health Econ</MedlineTA>
<NlmUniqueID>9306780</NlmUniqueID>
<ISSNLinking>1057-9230</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
<QualifierName UI="Q000600" MajorTopicYN="Y">supply & distribution</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003365" MajorTopicYN="N">Costs and Cost Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006296" MajorTopicYN="N">Health Services</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018803" MajorTopicYN="Y">Models, Economic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="Y">economics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D035501" MajorTopicYN="N">Uncertainty</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>10</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>10</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>1</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19816857</ArticleId>
<ArticleId IdType="doi">10.1002/hec.1549</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Pays-Bas</li>
</country>
</list>
<tree><noCountry><name sortKey="Feenstra, Talitha L" sort="Feenstra, Talitha L" uniqKey="Feenstra T" first="Talitha L" last="Feenstra">Talitha L. Feenstra</name>
<name sortKey="Lugner, Anna K" sort="Lugner, Anna K" uniqKey="Lugner A" first="Anna K" last="Lugnér">Anna K. Lugnér</name>
</noCountry>
<country name="Pays-Bas"><noRegion><name sortKey="Attema, Arthur E" sort="Attema, Arthur E" uniqKey="Attema A" first="Arthur E" last="Attema">Arthur E. Attema</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001245 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001245 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:19816857
   |texte=   Investment in antiviral drugs: a real options approach.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:19816857" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021

	Serveur d'exploration sur les pandémies grippales
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les pandémies grippales

Investment in antiviral drugs: a real options approach.

Investment in antiviral drugs: a real options approach.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki